The first non-invasive
Pre-Implantable
Cardiac Monitor
Nuubo is the first textile with integrated electrodes capable to record 2 ECG leads continuously for up to 30 days. Increase your patient’s satisfaction and compliance. Have more data to base your decisions on. Palpitations, Syncope, Cryptogenic Stroke are clinical indications where 30-day monitoring is recommended.
The Technology
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
The Technology
2 Min
In this video we would like to introduce you the benefits of Nuubo.
The Product
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
How it works
2 Min
In this video we would like to explain how our product works.
Proven Clinical Benefits
Yield of atrial fibrillation detectionwith TextileWearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry
Jorge Pagola h, Jesus Juega h, Jaume Francisco-Pascual i, Angel Moya i, Mireia Sanchis h, Alejandro Bustamante j, Anna Penalba j, Maria Usero k, Elisa Cortijo k, Juan F. Arenillas k, Ana I. Calleja k, Maria Sandin-Fuentes l, Jeronimo Rubio l, Fernando Mancha m, Irene Escudero-Martinez m, Francisco Moniche m, Reyes de Torres m, Sara Eichau m, Carlos E. González-Matos m, Ángela Vega m, Alonso A. Pedrote n, Eduardo Arana-Rueda n, Joan Montaner j,m, Carlos A. Molina h, Marian Muchada h, David Rodriguez-Luna h, Noelia Rodriguez h, Estela Sanjuan h, Marta Rubiera h, Sandra Boned h, Marc Ribóh, Estefania Montiel h, Jose Beato-Coelho h, Teresa González Alujas o, Arturo Evangelista o
Patient's Compliance
146 out of 154 completed the prescribed 28-days monitoring. Only 8 patients did not complete the monitoring due to discomfort with the vest.
DIAGNOSTIC YIELD
The diagnostic yield was 3 times higher with Nuubo. Longer monitoring time has higher a diagnostic yield.
Market Opportunity
12 M Holter test / year only in UE and USA.
HIGHLY PREVALENT
33 million
Have arrhythmia, incidence increases with age and risk factors Atrial Fibrillation is the most common arrhythmia
AFIB
40%
Lifetime risk of Atrial Fibrillation for individuals over age 55
STROKE
5x
Increased risk of stroke due to Atrial Fibrillation
HUGE PERSONAL COST
390.000
Deaths/year due to AF
Become part of our
sales team
Lead the change. We are looking for partners to introduce Nuubo to the world.
Log in
Please enter your ID
| Ileana Hocking | Ileana |
| Ken Bullock | Ken |
| The Heart Beat Clinic | heartbeat |
| Estudio Cohorte | COHORTE |
| Prosmedica | Prosmedica |
| Demo Sales | demosales |
| Demo Customer | democustomer |
| Newtech Italia | Newtech |
| Medsafe Latam | Medsafe |
| Novamedical Portugal | Novamedical |
| cudbein Brazil | cudbein |
| UKB Registry | ukb |
Using.nuubo.com is propriety of Nuubo.
www.nuubo.com